190 related articles for article (PubMed ID: 17255814)
1. Patent foramen ovale and cryptogenic stroke. A critical review.
Ballerini L; Cifarelli A; Ammirati A; Gimigliano F
J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):34-8. PubMed ID: 17255814
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
Schuchlenz HW; Weihs W; Berghold A; Lechner A; Schmidt R
Int J Cardiol; 2005 May; 101(1):77-82. PubMed ID: 15860387
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review.
Khairy P; O'Donnell CP; Landzberg MJ
Ann Intern Med; 2003 Nov; 139(9):753-60. PubMed ID: 14597460
[TBL] [Abstract][Full Text] [Related]
4. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Windecker S; Wahl A; Nedeltchev K; Arnold M; Schwerzmann M; Seiler C; Mattle HP; Meier B
J Am Coll Cardiol; 2004 Aug; 44(4):750-8. PubMed ID: 15312853
[TBL] [Abstract][Full Text] [Related]
5. [Cryptogenic stroke and patent foramen ovale].
Windecker S; Nedeltchev K; Wahl A; Meier B
Ther Umsch; 2003 Sep; 60(9):553-61. PubMed ID: 14579624
[TBL] [Abstract][Full Text] [Related]
6. Management of patients with stroke and a patent foramen ovale.
Rodriguez CJ; Homma S
Curr Cardiol Rep; 2004 Mar; 6(2):143-6. PubMed ID: 14759360
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
Butera G; Bini MR; Chessa M; Bedogni F; Onofri M; Carminati M
Ital Heart J; 2001 Feb; 2(2):115-8. PubMed ID: 11256538
[TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrent cerebral ischemia after patent foramen ovale closure: A single center observational study.
Gurgoglione FL; Vignali L; Cattabiani MA; Solinas E; Benatti G; Tadonio I; Barocelli F; Dizdari C; Tuttolomondo D; Ardissino D; Nicolini F; Niccoli G
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107448. PubMed ID: 37988831
[TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale in cryptogenic stroke: current understanding and management options.
Wu LA; Malouf JF; Dearani JA; Hagler DJ; Reeder GS; Petty GW; Khandheria BK
Arch Intern Med; 2004 May; 164(9):950-6. PubMed ID: 15136302
[TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale and recurrent stroke: another paradoxical twist.
Halperin JL; Fuster V
Circulation; 2002 Jun; 105(22):2580-2. PubMed ID: 12045158
[No Abstract] [Full Text] [Related]
11. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement.
Hung J; Landzberg MJ; Jenkins KJ; King ME; Lock JE; Palacios IF; Lang P
J Am Coll Cardiol; 2000 Apr; 35(5):1311-6. PubMed ID: 10758974
[TBL] [Abstract][Full Text] [Related]
12. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.
Mas JL; Arquizan C; Lamy C; Zuber M; Cabanes L; Derumeaux G; Coste J;
N Engl J Med; 2001 Dec; 345(24):1740-6. PubMed ID: 11742048
[TBL] [Abstract][Full Text] [Related]
13. Patent cardiac foramen ovale: stroke risk and closure.
Mohr JP; Homma S
Ann Intern Med; 2003 Nov; 139(9):787-8. PubMed ID: 14597465
[No Abstract] [Full Text] [Related]
14. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events.
Du ZD; Cao QL; Joseph A; Koenig P; Heischmidt M; Waight DJ; Rhodes J; Brorson J; Hijazi ZM
Catheter Cardiovasc Interv; 2002 Feb; 55(2):189-94. PubMed ID: 11835645
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
[TBL] [Abstract][Full Text] [Related]
16. Closure of patent foramen ovale in cryptogenic stroke: ready or not, here come the trials.
Blackshear JL
J Am Coll Cardiol; 2004 Aug; 44(4):759-61. PubMed ID: 15312854
[No Abstract] [Full Text] [Related]
17. Surgical prophylaxis of recurrent stroke in patients with patent foramen ovale: a pilot study.
Guffi M; Bogousslavsky J; Jeanrenaud X; Devuyst G; Sadeghi H
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):260-3. PubMed ID: 8751488
[TBL] [Abstract][Full Text] [Related]
18. [Transcatheter closure of patent foramen ovale in patients after cryptogenic stroke].
Demkow M; Ruzyłło W; Kwieciński H; Konka M; Kepka C; Opuchlik A; Pruszczyk P; Wilczyński J; Rydlewska-Sadowska W
Neurol Neurochir Pol; 2000; 34(5):1005-14. PubMed ID: 11253468
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
Wahl A; Krumsdorf U; Meier B; Sievert H; Ostermayer S; Billinger K; Schwerzmann M; Becker U; Seiler C; Arnold M; Mattle HP; Windecker S
J Am Coll Cardiol; 2005 Feb; 45(3):377-80. PubMed ID: 15680715
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry.
Alameddine F; Block PC
Catheter Cardiovasc Interv; 2004 Aug; 62(4):512-6. PubMed ID: 15274163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
